Table 1.
Characteristics before treatment.
| Total cohort n = 170 |
Control n = 71 |
DEX n = 99 |
p | |
|---|---|---|---|---|
| Age, years | 71 (61–80) | 70 (60.5–80) | 71 (61–79) | 0.56 |
| Female | 49 (29%) | 19 (27%) | 30 (30%) | |
| Charlson comorbidity index | 2.5 (2–4) | 2.5 (1.5–4) | 2.75 (2–5) | 0.24 |
| Obesity (BMI > 30) | 36 (21.17%) | 17 (23.9%) | 19 (19%) | 0.20 |
| pO2/FiO2, mmHg | 82 (69–108) | 82 (72–120) | 82 (68–105) | 0.14 |
| Respiratory rate (RR), pm | 30 (28–34) | 30 (28–33) | 30 (28–34) | 0.33 |
| FiO2, % | 80 (60–95) | 80 (60–95) | 80 (66–95) | 0.45 |
| Lactate, mmol/L | 1 (1–5) | 2 (1–5) | 1 (1–5) | 0.23 |
| C-reactive protein (CRP), mg/dL | 6 (3–10) | 6 (3–9.5) | 6 (3–10) | 0.32 |
| SARS-CoV-2 vaccine | 110 (64.7%) | 46 (64.8%) | 64 (64.6%) |
Results are expressed as median and IQR or number and percentage.